Aminoglycosides are used to treat infections caused by carbapenem-resistant Acinetobacter
baumannii (CRAB) strains. However, resistance to aminoglycosides has increased …

Acinetobacter baumannii strains belonging to global clone 2 (GC2) contain resistance
islands (AbGRIs), which are composed of genes conferring resistance to older and newer …

Background: Acinetobacter baumannii is one of the major causes of nosocomial infections
and is resistant to most available antibiotics. Aminoglycosides remain as drugs of choice for …

Background: Acinetobacter baumannii (A. baumannii) is an opportunistic pathogen
associated with serious hospital acquired infections. It is resistant to multiple antibiotics. The …

In Acinetobacter baumannii (A. baumannii), a wide repertoire of resistance genes is often
carried within genomic resistance islands (RIs), particularly in high-risk global clones (GCs) …

The worldwide distribution of carbapenem-resistant Acinetobacter baumannii (CRAB) has
become a global concern, particularly in countries where antibiotic prescription is not tightly …

Objectives: To investigate the context of the ribosomal RNA methyltransferase gene armA in
carbapenem-resistant global clone 2 (GC2) Acinetobacter baumannii isolates from …

Acinetobacter baumannii is a major cause of nosocomial infection, and the incidence of
extensively drug-resistant A. baumannii (XDRAB) infections has dramatically increased …

Objectives To determine the context and location of antibiotic resistance genes in
carbapenem-and aminoglycoside-resistant Acinetobacter baumannii global clone 2 (GC2) …

Abstract Background and Objectives: ACINETOBACTER BAUMANNII is one of the major
causes of nosocomial infections resistant to most of available antibiotics, which is known as …